Randomized placebo‐controlled trial comparing fluticasone aqueous nasal spray in mono‐therapy, fluticasone plus cetirizine, fluticasone plus montelukast and cetirizine plus montelukast for seasonal allergic rhinitis

Abstract

In [1], an incorrect version of Table 2 was published on page 264. The correct table is displayed below.

Clinical efficacy of potassium humate in the treatment of allergic rhinitis: double‐blind placebo‐controlled trial

“…When comparing the smears of the two groups it was found that there is a significant difference between the two groups showing that the treated groups' nasal eosinophil recruitment had significantly decreased, which correlates with results obtained with other therapies for hay fever [Di Lorenzo et al, 2004]. No effect on basophil stimulation and thus histamine release was observed, and could therefore have a more specific anti-inflammatory effect.…”

Allergic Rhinitis and its Impact on Asthma (ARIA) 2008*

“…Combination between drugs has been tested, but insufficient data are available to make a recommendation concerning the combined use of oral H 1 -antihistamines and intranasal glucocorticosteroids (1099,1594,1595). The combination of oral H 1 -antihistamines and leukotriene receptor antagonists does not increase the efficacy of any single drug and is less effective than intranasal corticosteroids (1594,1596,1597).…”

The Effect of Combined Medical Treatment on Quality of Life in Persistent Allergic Rhinitis

“…In one study of perennial rhinitis, montelukast was found to be superior to placebo [22], but in another study its effects were not superior to placebo and were similar to cetirizine after 1 month of treatment [23]. It has also been reported that the combination of oral H1-antihistaminics and leukotriene receptor antagonists does not increase the efficacy of any single drug and is less effective than intranasal corticosteroids [24][25][26]. In our study, montelukast plus mometasone furoate was found to be most effective in the improvement of nasal obstruction.…”